4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Eris Lifesciences Limited (ERIS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Ahmedabad, India with about 2,758 employees. Its market capitalization is roughly ₹183 billion. In the fiscal year ended 2026-03-31, ERIS reported ₹31.1B in revenue and ₹6.2B in net income.
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹31.1B | ₹28.8B | ₹19.9B | ₹16.6B | — |
| Gross Profit | ₹23.0B | ₹21.5B | ₹16.0B | ₹13.0B | — |
| Operating Income (EBIT) | ₹8.4B | ₹7.0B | ₹5.0B | ₹4.2B | — |
| Net Income | ₹6.2B | ₹3.5B | ₹3.9B | ₹3.8B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹8.7B | ₹7.5B | ₹8.0B | ₹7.9B | ₹7.7B | — |
| Gross Profit | ₹6.3B | ₹5.7B | ₹5.8B | ₹5.9B | ₹5.9B | — |
| Operating Income (EBIT) | ₹2.2B | ₹2.0B | ₹2.1B | ₹2.2B | ₹2.1B | — |
| Net Income | ₹1.4B | ₹2.8B | ₹997M | ₹1.2B | ₹1.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | (₹1.0B) | — | (₹999M) | (₹816M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹73.7B | ₹70.4B | ₹70.4B | ₹36.7B | — |
| Total Liabilities | ₹34.7B | ₹37.6B | ₹38.2B | ₹14.5B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ERIS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms